Genetic analysis of early- versus late-stage ovarian tumors

Viji Shridhar, Ajay Pandita, Rajeswari Avula, Julie Staub, Eric Calhoun, Patrick Roche, C. David James, Fergus J. Couch, David I. Smith, Steve Iturria, Kimberly Kalli, Gary Keeney, William Cliby, Lynn C. Hartmann, John Lee, Mike Morrissey, Ami Sen, Jim Lillie, Karen Lu, Rosemarie Schmandt & 2 others Gordon Mills, Robert Bast

Research output: Contribution to journalArticle

185 Citations (Scopus)

Abstract

In the United States, ovarian cancer is the fourth most common cause of cancer-related deaths among women. The most important prognostic factor for this cancer is tumor stage, or extent of disease at diagnosis. Although women with low-stage tumors have a relatively good prognosis, most women diagnosed with late-stage disease eventually succumb to their cancer. In an attempt to understand early events in ovarian carcinogenesis, and to explore steps in its progression, we have applied multiple molecular genetic techniques to the analysis of 21 early-stage (stage I/II) and 17 advanced-stage (stage III/IV) ovarian tumors. These techniques included expression profiling with cDNA microarrays containing approximately 18, 000 expressed sequences, and comparative genomic hybridization to address the chromosomal locations of copy number gains as well as losses. Results from the analysis indicate that early-stage ovarian cancers exhibit profound alterations in gene expression, many of which are similar to those identified in late-stage tumors. However, differences observed at the genomic level suggest differences between the early- and late-stage tumors and provide support for a progression model for ovarian cancer development.

Original languageEnglish (US)
Pages (from-to)5895-5904
Number of pages10
JournalCancer Research
Volume61
Issue number15
StatePublished - Aug 1 2001
Externally publishedYes

Fingerprint

Neoplasms
Ovarian Neoplasms
Genetic Techniques
Comparative Genomic Hybridization
Oligonucleotide Array Sequence Analysis
Molecular Biology
Carcinogenesis
Gene Expression

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Shridhar, V., Pandita, A., Avula, R., Staub, J., Calhoun, E., Roche, P., ... Bast, R. (2001). Genetic analysis of early- versus late-stage ovarian tumors. Cancer Research, 61(15), 5895-5904.

Genetic analysis of early- versus late-stage ovarian tumors. / Shridhar, Viji; Pandita, Ajay; Avula, Rajeswari; Staub, Julie; Calhoun, Eric; Roche, Patrick; James, C. David; Couch, Fergus J.; Smith, David I.; Iturria, Steve; Kalli, Kimberly; Keeney, Gary; Cliby, William; Hartmann, Lynn C.; Lee, John; Morrissey, Mike; Sen, Ami; Lillie, Jim; Lu, Karen; Schmandt, Rosemarie; Mills, Gordon; Bast, Robert.

In: Cancer Research, Vol. 61, No. 15, 01.08.2001, p. 5895-5904.

Research output: Contribution to journalArticle

Shridhar, V, Pandita, A, Avula, R, Staub, J, Calhoun, E, Roche, P, James, CD, Couch, FJ, Smith, DI, Iturria, S, Kalli, K, Keeney, G, Cliby, W, Hartmann, LC, Lee, J, Morrissey, M, Sen, A, Lillie, J, Lu, K, Schmandt, R, Mills, G & Bast, R 2001, 'Genetic analysis of early- versus late-stage ovarian tumors', Cancer Research, vol. 61, no. 15, pp. 5895-5904.
Shridhar V, Pandita A, Avula R, Staub J, Calhoun E, Roche P et al. Genetic analysis of early- versus late-stage ovarian tumors. Cancer Research. 2001 Aug 1;61(15):5895-5904.
Shridhar, Viji ; Pandita, Ajay ; Avula, Rajeswari ; Staub, Julie ; Calhoun, Eric ; Roche, Patrick ; James, C. David ; Couch, Fergus J. ; Smith, David I. ; Iturria, Steve ; Kalli, Kimberly ; Keeney, Gary ; Cliby, William ; Hartmann, Lynn C. ; Lee, John ; Morrissey, Mike ; Sen, Ami ; Lillie, Jim ; Lu, Karen ; Schmandt, Rosemarie ; Mills, Gordon ; Bast, Robert. / Genetic analysis of early- versus late-stage ovarian tumors. In: Cancer Research. 2001 ; Vol. 61, No. 15. pp. 5895-5904.
@article{697d5bec21cb479d882fe5426525eeaf,
title = "Genetic analysis of early- versus late-stage ovarian tumors",
abstract = "In the United States, ovarian cancer is the fourth most common cause of cancer-related deaths among women. The most important prognostic factor for this cancer is tumor stage, or extent of disease at diagnosis. Although women with low-stage tumors have a relatively good prognosis, most women diagnosed with late-stage disease eventually succumb to their cancer. In an attempt to understand early events in ovarian carcinogenesis, and to explore steps in its progression, we have applied multiple molecular genetic techniques to the analysis of 21 early-stage (stage I/II) and 17 advanced-stage (stage III/IV) ovarian tumors. These techniques included expression profiling with cDNA microarrays containing approximately 18, 000 expressed sequences, and comparative genomic hybridization to address the chromosomal locations of copy number gains as well as losses. Results from the analysis indicate that early-stage ovarian cancers exhibit profound alterations in gene expression, many of which are similar to those identified in late-stage tumors. However, differences observed at the genomic level suggest differences between the early- and late-stage tumors and provide support for a progression model for ovarian cancer development.",
author = "Viji Shridhar and Ajay Pandita and Rajeswari Avula and Julie Staub and Eric Calhoun and Patrick Roche and James, {C. David} and Couch, {Fergus J.} and Smith, {David I.} and Steve Iturria and Kimberly Kalli and Gary Keeney and William Cliby and Hartmann, {Lynn C.} and John Lee and Mike Morrissey and Ami Sen and Jim Lillie and Karen Lu and Rosemarie Schmandt and Gordon Mills and Robert Bast",
year = "2001",
month = "8",
day = "1",
language = "English (US)",
volume = "61",
pages = "5895--5904",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Genetic analysis of early- versus late-stage ovarian tumors

AU - Shridhar, Viji

AU - Pandita, Ajay

AU - Avula, Rajeswari

AU - Staub, Julie

AU - Calhoun, Eric

AU - Roche, Patrick

AU - James, C. David

AU - Couch, Fergus J.

AU - Smith, David I.

AU - Iturria, Steve

AU - Kalli, Kimberly

AU - Keeney, Gary

AU - Cliby, William

AU - Hartmann, Lynn C.

AU - Lee, John

AU - Morrissey, Mike

AU - Sen, Ami

AU - Lillie, Jim

AU - Lu, Karen

AU - Schmandt, Rosemarie

AU - Mills, Gordon

AU - Bast, Robert

PY - 2001/8/1

Y1 - 2001/8/1

N2 - In the United States, ovarian cancer is the fourth most common cause of cancer-related deaths among women. The most important prognostic factor for this cancer is tumor stage, or extent of disease at diagnosis. Although women with low-stage tumors have a relatively good prognosis, most women diagnosed with late-stage disease eventually succumb to their cancer. In an attempt to understand early events in ovarian carcinogenesis, and to explore steps in its progression, we have applied multiple molecular genetic techniques to the analysis of 21 early-stage (stage I/II) and 17 advanced-stage (stage III/IV) ovarian tumors. These techniques included expression profiling with cDNA microarrays containing approximately 18, 000 expressed sequences, and comparative genomic hybridization to address the chromosomal locations of copy number gains as well as losses. Results from the analysis indicate that early-stage ovarian cancers exhibit profound alterations in gene expression, many of which are similar to those identified in late-stage tumors. However, differences observed at the genomic level suggest differences between the early- and late-stage tumors and provide support for a progression model for ovarian cancer development.

AB - In the United States, ovarian cancer is the fourth most common cause of cancer-related deaths among women. The most important prognostic factor for this cancer is tumor stage, or extent of disease at diagnosis. Although women with low-stage tumors have a relatively good prognosis, most women diagnosed with late-stage disease eventually succumb to their cancer. In an attempt to understand early events in ovarian carcinogenesis, and to explore steps in its progression, we have applied multiple molecular genetic techniques to the analysis of 21 early-stage (stage I/II) and 17 advanced-stage (stage III/IV) ovarian tumors. These techniques included expression profiling with cDNA microarrays containing approximately 18, 000 expressed sequences, and comparative genomic hybridization to address the chromosomal locations of copy number gains as well as losses. Results from the analysis indicate that early-stage ovarian cancers exhibit profound alterations in gene expression, many of which are similar to those identified in late-stage tumors. However, differences observed at the genomic level suggest differences between the early- and late-stage tumors and provide support for a progression model for ovarian cancer development.

UR - http://www.scopus.com/inward/record.url?scp=0035421991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035421991&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 5895

EP - 5904

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 15

ER -